Publications produced by the EDRN investigators.
The following is a list of publications authored by EDRN investigators. You may sort and filter the results by both author and journal.
. Deregulated EGFR signaling during lung cancer progression: Mutations, amplicons, and autocrine loops
—Minna JD, Gazdar AF
. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
—Goodglick L., Maresh EL, Pietras R, Mah V, Horvath S, Fishbein MC, Chia D, Bagryanova L, Zhang L, Yoon N, Alavi M, Marquez D
. Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
—Goodglick L., Maresh E, Seligson DB, Li A, Mah V, Horvath S, Chia D, Elshimali Y, Yoon NK, Bonavida B, Bose S, Sulur G
2-D or not 2-D is there a fututre for 2-D gels in proteomics? Insights from the York proteomic meeting
2D Differential In-gel Electrophoresis (DIGE) for the Identification of Esophageal Squamous Cell Cancer-Specific Protein Markers
—Flaig M, Li H, Taylor PR, Shu H, DeCamp D, Petricoin III EF, Gong Y, Zhao Y, Emmert-Buck MR, Gillespie JW, Liotta LA, Chen S, Zhou G, Hu N
4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene
—Beland FA, Feng Z, Rom WN, Tang M-s, Hu W
[-2]proPSA for prostate cancer detection: an NCI Early Detection Research Network validation study.
—Thompson IM, Kagan J, Sokoll LJ, Sanda MG, Chan DW, Partin AW, Wang Y, Feng Z
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.
A data-analytic strategy for protein-biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
—Wright G Jr, Thompson ML, Feng Z, Potter JD, Adam B-L, Thornquist M, Yasui Y, Qu Y, Winget M, Pepe M
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis
—Hanash SM and Beretta L, Brichory F, Brechot C, Misek DE, Le Naour F
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
—van der Klift H, Lynch HT, Coronel SM, Wijnen J, Wagnr A, Fodde R, Barrows A, de la Chapelle A, Okimoto R, Franken P, Sweet K, Hampel H, Lynch JF
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
A functional annotation of subproteomes in human plasma
—Hancock WS, Vondriska TM, Raftery M, Gronborg M, Pandey A, Rekha B, Wasinger V, Ping P, Gerszten RE, Drwal G, States DJ, Peri S, Wu H, Kellmann M, Yang Z, Molina H, Schulz-Knappe P, Chaerkady R, Suresh S, Gandhi TK, Creighton CJ, Shet AS, Paik YK, Omenn GS, Cho SY, Hanash SM, Kwon MS, Menon R
A functional arginine residue in NADPH-dependent aldehyde reductase from pig kidney.
A functional link between adhesion and proteolysis in ovarian epithelial ovarian carcinoma cells
—Fishman DA, Stack MS, Bafetti LM, Kearns A
A genetic analysis of extinction: Trans-dominant loci regulate expression of liver-specific genes in hepatoma hybrid cells
—Fournier REK, Killary AM
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
—Naylor SL, Minna JD, Daly MC, Garcia DK, Buchhagen D, Hensel CH, Xiang R-H, Killary AM
A lung cancer protein database
—Tra, F., E., Brichory, Puravs, Beer, D. and Hanash S, Oh, J.